DK0984019T3 - C11-carbamater fra antibakterielle macrolider - Google Patents
C11-carbamater fra antibakterielle macroliderInfo
- Publication number
- DK0984019T3 DK0984019T3 DK99306034T DK99306034T DK0984019T3 DK 0984019 T3 DK0984019 T3 DK 0984019T3 DK 99306034 T DK99306034 T DK 99306034T DK 99306034 T DK99306034 T DK 99306034T DK 0984019 T3 DK0984019 T3 DK 0984019T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- formula
- relates
- carbamates
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9707598P | 1998-08-19 | 1998-08-19 | |
US10478598P | 1998-10-19 | 1998-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0984019T3 true DK0984019T3 (da) | 2004-08-30 |
Family
ID=26792507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99306034T DK0984019T3 (da) | 1998-08-19 | 1999-07-29 | C11-carbamater fra antibakterielle macrolider |
Country Status (10)
Country | Link |
---|---|
US (1) | US6043227A (da) |
EP (1) | EP0984019B1 (da) |
JP (1) | JP2000063397A (da) |
AT (1) | ATE268337T1 (da) |
BR (1) | BR9903737A (da) |
CA (1) | CA2280328C (da) |
DE (1) | DE69917717T2 (da) |
DK (1) | DK0984019T3 (da) |
ES (1) | ES2220008T3 (da) |
PT (1) | PT984019E (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6710033B1 (en) | 1996-08-14 | 2004-03-23 | Vanderbilt University | Methods and treatment of multiple sclerosis |
US6890526B2 (en) | 1997-05-06 | 2005-05-10 | Vanderbilt University | Methods and reagents for the treatment of multiple sclerosis |
AP9801420A0 (en) * | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
AP1060A (en) * | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
CA2411293A1 (en) * | 1999-01-28 | 2000-07-28 | Pfizer Products Inc. | Novel azalides and methods of making same |
WO2000071557A1 (en) * | 1999-05-24 | 2000-11-30 | Pfizer Products Inc. | 13-methyl-erythromycin derivatives |
EP1101769A3 (en) | 1999-11-18 | 2001-10-24 | Pfizer Products Inc. | Nitrogen containing erythromycin derivatives |
WO2001070239A1 (en) * | 2000-03-22 | 2001-09-27 | Thomas Jefferson University | Use of azithromycin for infections with leishmania |
US20040186063A1 (en) * | 2002-02-15 | 2004-09-23 | Hans-Jurgen Gutke | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
AU2003215245A1 (en) * | 2002-02-15 | 2003-09-09 | Sympore Gmbh | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
NZ535354A (en) | 2002-02-15 | 2008-01-31 | Merckle Gmbh | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
AU2003211113B2 (en) * | 2002-02-15 | 2007-08-09 | Merckle Gmbh | Antibiotic conjugates |
CN1665831A (zh) | 2002-07-08 | 2005-09-07 | 普利瓦研究院有限公司 | 作为甾类/非甾类抗炎、抗肿瘤和抗病毒活性分子载体的新化合物、组合物 |
NZ537716A (en) * | 2002-07-08 | 2007-05-31 | Glaxosmithkline Zagreb | Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
RS20050008A (en) | 2002-07-08 | 2007-06-04 | Pliva-Istraživački Institut D.O.O., | New compounds,compositions and methods for treatment of inflammatory diseases and conditions |
AU2006274197A1 (en) * | 2005-07-26 | 2007-02-01 | Merckle Gmbh | Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase |
CN101423539B (zh) * | 2008-12-09 | 2011-04-27 | 山东大学 | 4″,11-二氨基甲酸酯阿奇霉素衍生物、制备方法及其药物组合物 |
FR2995605B1 (fr) * | 2012-09-18 | 2014-09-19 | Sanofi Sa | Derives de macrolides, leur preparation et leur application therapeutique. |
CN104844671B (zh) * | 2015-05-19 | 2017-07-04 | 山东大学 | 11‑o‑芳烷基氨基甲酸酯克拉霉素衍生物及其制备方法与应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI8110592A8 (en) * | 1981-03-06 | 1996-06-30 | Pliva Pharm & Chem Works | Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof |
PH19293A (en) * | 1982-11-15 | 1986-03-04 | Pfizer | Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof |
US4464527A (en) * | 1983-06-30 | 1984-08-07 | Pfizer Inc. | Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore |
KR880009960A (ko) * | 1987-02-24 | 1988-10-06 | 데이빗 로버츠 | 화학적 화합물 |
US5350839A (en) * | 1990-10-15 | 1994-09-27 | Taisho Pharmaceutical Co., Ltd. | 2'-position modified compound of erythromycin or its derivative |
CA2064634C (en) * | 1991-04-04 | 1998-08-04 | James V. Heck | 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions |
HRP930014A2 (en) * | 1993-01-08 | 1994-08-31 | Pliva Pharm & Chem Works | 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates |
HN1998000074A (es) * | 1997-06-11 | 1999-01-08 | Pfizer Prod Inc | Derivados de macrolidos c-4 sustituidos |
HN1998000086A (es) * | 1997-06-11 | 1999-03-08 | Pfizer Prod Inc | Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos. |
HRP970714B1 (en) * | 1997-12-31 | 2003-08-31 | Pliva Pharm & Chem Works | Beta,beta-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a |
AP9801420A0 (en) * | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
-
1999
- 1999-05-26 US US09/320,352 patent/US6043227A/en not_active Expired - Fee Related
- 1999-07-29 DK DK99306034T patent/DK0984019T3/da active
- 1999-07-29 PT PT99306034T patent/PT984019E/pt unknown
- 1999-07-29 DE DE69917717T patent/DE69917717T2/de not_active Expired - Fee Related
- 1999-07-29 AT AT99306034T patent/ATE268337T1/de not_active IP Right Cessation
- 1999-07-29 EP EP99306034A patent/EP0984019B1/en not_active Expired - Lifetime
- 1999-07-29 ES ES99306034T patent/ES2220008T3/es not_active Expired - Lifetime
- 1999-08-17 CA CA002280328A patent/CA2280328C/en not_active Expired - Fee Related
- 1999-08-18 BR BR9903737-8A patent/BR9903737A/pt not_active IP Right Cessation
- 1999-08-19 JP JP11232449A patent/JP2000063397A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2000063397A (ja) | 2000-02-29 |
ES2220008T3 (es) | 2004-12-01 |
DE69917717T2 (de) | 2004-09-23 |
EP0984019A1 (en) | 2000-03-08 |
PT984019E (pt) | 2004-08-31 |
US6043227A (en) | 2000-03-28 |
DE69917717D1 (de) | 2004-07-08 |
BR9903737A (pt) | 2000-09-19 |
CA2280328A1 (en) | 2000-02-19 |
CA2280328C (en) | 2005-07-26 |
EP0984019B1 (en) | 2004-06-02 |
ATE268337T1 (de) | 2004-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0984019T3 (da) | C11-carbamater fra antibakterielle macrolider | |
MY133027A (en) | C-4"-substituted macrolide derivatives | |
MY123354A (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
AU2134402A (en) | Antiviral agents | |
DE69716810D1 (de) | 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one | |
MY122353A (en) | 13-membered azalides and their use as antibiotic agents | |
GT199900208A (es) | Antibiòticos cetòlidos carbamato y carbazato. | |
ATE277062T1 (de) | Neue makrolidderivate | |
DE60102171D1 (de) | Ketolidantibiotika | |
PT1167376E (pt) | Antibioticos macrolidos | |
BR9902049A (pt) | Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina. |